AndhraNews.net
Home » Features » Health » Colon cancer

Colon cancer


About Colon cancer

A new study shows obese colon cancer patients are at greater risk for death or recurrent disease compared to those who are within a normal weight range.

Celebrities with Colon cancer

Television series Dynasty star John Forsythe died after a long battle with cancer.

Colon cancer in News

Curb Energy Consumption
(Family Features) Water heaters are energy intensive appliances. In fact, they are the second largest energy user in the home, and as they age, they become less efficient, requiring even more energy.

Funk Out Cancer and Widen Raise Over $53,000 for Cancer Research
MADISON, WI--(Marketwired - December 04, 2015) - Widen Enterprises, makers of digital asset management software (DAM), announced that the company has helped Funk Out Cancer raise $53,023 to fund research in Dr. Dustin Deming's lab at the University of Wisconsin Paul C. Carbone Cancer Center

CORRECTION - American Cancer Society Helps Cancer Patients Get to Care
ATLANTA, GA--(Marketwired - November 09, 2015) - In the news release, "American Cancer Society Helps Cancer Patients Get to Care" issued earlier today by the American Cancer Society, we are advised by the company that the quote in the second paragraph should be attributed to Raul Duany rather than Gary M. Reedy as originally issued. Complete corrected text follows.

American Cancer Society Helps Cancer Patients Get to Care
ATLANTA, GA--(Marketwired - November 09, 2015) - The American Cancer Society today launched a video series highlighting the unmet access to care needs of thousands associated with cancer treatment

Phytosterols Market Size to Reach $989.8 Million by 2020: Grand View Research, Inc.
The global phytosterols market is expected to reach USD 989.8 million by 2020, according to a new study by Grand View Research, Inc. Phytosterols are widely used as additives in food products such as dairy, sausages, cold cuts, etc. One of the major drivers for the growth of phytosterols market is the favorable regulatory scenario, promoting their use in functional foods and nutraceuticals

EDP Biotech Achieves ISO 13485 Certification
EDP Biotech, a privately-held company providing in-vitro diagnostic test kits for the detection of colorectal cancer, has achieved ISO 13485 and Canadian Medical Device Regulations Certification

OPKO Health, Inc. Participates in Latest Round of Financing for MabVax Therapeutics
SAN DIEGO, CA--(Marketwired - October 08, 2015) - MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) ("MabVax" or "Company"), a clinical-stage cancer immunotherapy company, previously announced that it has closed its public offering of 2,500,000 shares of its common stock and warrants to purchase up to 1,250,000 shares of its common stock

Dr. Edward Eyring Appointed to Chief Executive Officer of Nutranomics
Nutranomics, Inc. (OTC PINK: NNRX) ("Nutranomics" or "The Company"), a diversified nutraceutical formulator, supplement manufacturer and marketer of Nutranomics® health supplements, today announced the appointment of Dr. Edward "Joe" Eyring, past Board certified surgeon and healthcare entrepreneur, to assume CEO responsibilities from Mr. Michael Doron. Neither the Company nor Mr

MabVax Therapeutics Holdings Obtains Release of $3.5 Million in Escrowed Funds
SAN DIEGO, CA--(Marketwired - July 01, 2015) - MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) ("MabVax" or the "Company"), a clinical stage immuno-oncology drug development company, announced today that it, collectively with OPKO Health, Inc. (NYSE: OPK), approved the release of $3.5 million in funds held in escrow from the $11.7 million financing the Company completed on April 10, 2015.

Boston Medical Center Selects PFS Clinical for Coverage Analysis of Clinical Research Trials
PFS Clinical, which offers turnkey administration solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by the Boston Medical Center (BMC) Clinical Trial Office to provide Medicare Coverage Analysis (CA) of its clinical research trials

PharmaCyte Biotech's Cancer Treatment Shows "Complete Tumor Remission" in Published Preclinical Study
NEW YORK, NY--(Marketwired - June 03, 2015) - PharmaCyte Biotech’s (OTCQB: PMCB) signature live-cell encapsulation technology, Cell-in-a-Box®, was the star of the show in a recently released corporate video by the company

Hansen Medical(R) Announces World's First Series in Robotic Cancer Treatment With the Magellan Robotic System
Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the completion of the world's first robotically-assisted radioembolization procedures for cancer treatment. The procedures, utilizing the Magellan Robotic System, were performed by Interventional Radiologists Dr. Francis Schlueter at Good Samaritan Hospital in Cincinnati, OH and Dr

EDP Biotech Triples Knoxville Office/Lab Space for European ColoMarker Launch
EDP Biotech Corporation (EDP), a global in vitro diagnostic innovator of ColoMarker®, a simple, blood-based early stage cancer diagnostic test, announces it has more than tripled its office and laboratory footprint in preparation for an upcoming European product launch.

MabVax Therapeutics Holdings, Inc. Provides Corporate Update and Reports First Quarter 2015 Financial Results
SAN DIEGO, CA--(Marketwired - May 15, 2015) - MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), a clinical stage oncology drug development company, provided today a corporate update and reported financial results for the first quarter ended March 31, 2015.

Advanced Proteome Therapeutics' Lead Compound Inhibits Metastasis in Breast Cancer Tumor Model
VANCOUVER, BC--(Marketwired - April 29, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its current lead compound APC 101 successfully diminished the frequency of tumor metastasis in the 4T1 animal model.

MabVax Therapeutics Catches Eye of Billionaire Investor Dr. Phillip Frost and OPKO Health
NEW YORK, NY--(Marketwired - April 08, 2015) - Investors at MabVax Therapeutics (OTCQB: MBVX) must feel like they're in just the right place at just the right time this week as news of billionaire Bio-Pharma Investor Dr. Phillip Frost, M.D., and his company OPKO Health (NYSE: OPK) have taken a strong interest in the clinical stage cancer immunotherapy company -- a $12 million interest.  Dr

EDP Biotech Signs Distribution Partnership Agreements for ColoMarker(R) Abroad
EDP Biotech Corporation (EDP), a global in vitro diagnostic innovator of a simple blood-based cancer diagnostic test, announces it has entered into distribution agreements with more than twenty-five market leading distribution channel partners throughout Europe, Asia, and South America

Powerful New "Tips From Former Smokers" Ads Focus on Living With Vision Loss and Colorectal Cancer
NEW YORK, NY--(Marketwired - March 26, 2015) - The Centers for Disease Control and Prevention is launching its 2015 "Tips From Former Smokers" campaign with a series of powerful new ads featuring former smokers who suffer from smoking-related illnesses, including vision loss and colorectal cancer.

Corporate Social Responsibility Weekly Recap (April 29, 2015 – May 6, 2015)
Business Wire IndiaThe following releases focus on Corporate Social Responsibility and moved during the week of April 29, 2015 – May 6, 2015.

New Survey Showed GI Health and Anti-Aging Benefits of Morinaga's Probiotics Milk with BB536
Business Wire IndiaMorinaga Milk Industry Co., Ltd

Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder
Novartis International AG /Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

ActiveYards(R) and Certified Dealers' Contribute to Charitable Efforts Close to Community Hearts
ActiveYards® distributes low maintenance fencing solutions with leading designs and exclusive technologies through a highly reputable and experienced dealer network that does great work on the job as well as off the job by volunteering and playing their part in bringing awareness to local and nationwide charities.

Novartis drug Signifor® approved in EU, marking an advance for patients with inadequately controlled acromegaly
Novartis International AG /Novartis drug Signifor® approved in EU, marking an advance for patients with inadequately controlled acromegaly . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Looking Back: 20 Years of Colorectal Cancer Treatment Breakthroughs Improve Survival, Advance Evidence-Based Choices
FORT WASHINGTON, PA--(Marketwired - October 09, 2014) - The National Comprehensive Cancer Network® (NCCN®) has published the 20th annual editions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Colon and Rectal Cancers, two of the eight original NCCN Guidelines® published in November 1996. 

IsoRay, Inc. Reports Fiscal Year 2014 Results
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced its financial results for the quarter and year ended June 30, 2014.

Novartis drug Signifor® LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly
Novartis International AG /Novartis drug Signifor® LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Peregrine Pharmaceuticals Reports Fourth Quarter and Year-End Fiscal Year 2014 Financial Results and Recent Developments
Peregrine Pharmaceuticals, Inc

You Are What You Eat: Food Choices and Cancer Risk
This month, researchers at the nonprofit Physicians Committee of Responsible Medicine published new cancer prevention dietary guidelines. The recommendations, culled from varied cancer risk studies, are designed to increase consumer awareness about the very real connection between nutrition and disease

Hansen Medical Reports Recent Business Highlights and First Quarter 2014 Results
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the first quarter of fiscal year 2014 ended March 31, 2014.

Novartis drug Signifor® LAR shows superior efficacy in acromegaly patients not controlled on first generation somatostatin analogues
Novartis International AG /Novartis drug Signifor® LAR shows superior efficacy in acromegaly patients not controlled on first generation somatostatin analogues . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Hansen Medical Announces World's First Clinical Cases With New Magellan(TM) 6Fr Robotic Catheter
Hansen Medical, Inc. (NASDAQ: HNSN), announced today the successful completion of the world's first clinical procedures using the Magellan™ 6Fr Robotic Catheter. Professor Marc Sapoval, MD, PhD and Dr. Olivier Pellerin, MD, MSc treated three patients with the 6Fr catheter over the span of two days at Hôpital Européen Georges Pompidou (APHP)

Data Presented at AACR Support Potential of Peregrine's PS-Targeting Immunotherapy Bavituximab to Enhance Anti-Tumor and Immune-Stimulating Effects of Anti-CTLA-4 and Anti-PD-1 Treatments in Models of Melanoma and Colon Cancer
Peregrine Pharmaceuticals, Inc

Look Who's Working to Prevent Colon Cancer...
CLIVE, IA--(Marketwired - March 27, 2014) -

NCCN 19th Annual Conference Opening Roundtable: Communication Is Key for Children of Parents With Cancer
FORT WASHINGTON, PA--(Marketwired - March 18, 2014) - On March 13, 2014, The National Comprehensive Cancer Network® (NCCN®) opened its 19th Annual Conference: Advancing the Standard of Cancer Care™ with a roundtable discussion titled, The Child's Experience When a Parent has Cancer. The panel, moderated by Lillie D

Colonoscopy Screening for Colon Cancer: Just One Day Could Save Your Life
Studies have confirmed that screening for colon cancer is a contributing factor to declining colon cancer death rates

Adamis Receives Notice of Key Allowance for US Patent That Supports Its Cancer Immunology Portfolio
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced an important addition to its intellectual property with receipt of a Notice of Allowance of patent claims supporting its cancer immunotherapy portfolio in the United States. Notice of Allowance is the final step in the issuance of a patent

Chicago Dentist Says Routine Dental Visits Can Help Prevent Oral Infection and Even Life-Threatening Disease
Dr. Sheldon Seidman, a cosmetic dentist in Chicago, says when patients begin to notice problems in the mouth, this usually means an oral infection may already exist and could have progressed to other parts of the body, posing even greater health risks. Dr

Three Tips for Staying Healthy Over 50
(Family Features) A healthy lifestyle is necessary at any age, but for those over 50, it's especially important. As you age, your body changes, and your risk for health problems increases. Fortunately, there are three simple things you can do to lead a healthier and happier life.

EDP Biotech Announces CE Mark Approval for ColoMarker an in Vitro Diagnostic Aid in Early Detection of Colon Cancer and Plans for Commercialization in Europe
EDP Biotech Corporation, (“EDP,” or the “Company”), a global in vitro diagnostic innovator of life-saving, easy-to-use cancer diagnostic tests using ELISA technology, has announced CE Mark approval for ColoMarker® , an aid in early detection of Colon Cancer

Pathway Genomics Launches Hereditary Colorectal Cancer Genetic Test
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, has announced the launch of Hereditary Colorectal Cancer DNA InsightSM, the company’s premier hereditary cancer genetic test

University of California San Diego and John Muir Medical Center Initiated Treating Patients for Colon and Lung Cancer Utilizing IsoRay's Cesium-131 Seeded Mesh
IsoRay Inc. (NYSE MKT: ISR) (www.isoray.com), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it has two new medical centers using its sutured seeds in mesh to treat colon and lung cancers.

Profile of Pediatric IBD: Initial Findings From CCFA Partners Kids & Teens

Widen Helps Funk Out Cancer Raise Over $41,000 for Cancer Research
Widen Enterprises, makers of digital asset management software (DAM), announced that the company has helped Funk Out Cancer raise $41,296 for the University of Wisconsin Paul C. Carbone Cancer Center

Soricimed Shows Promise in Treating Breast and Ovarian Cancer
Soricimed Biopharma Inc

Conversant Bio Publishes New E-book to Help Biomedical Researchers Understand How to Choose a FFPE Supplier
Conversant Bio, a global leader in supplying the highest quality human tissue and viable cell samples, today announced it is publishing a new E-book to assist researchers in looking for FFPE samples for their drug discovery and biomedical research efforts

Widen Enterprises Presents Funk Out Cancer
Widen Enterprises, makers of digital asset management software (DAM), announced today that the company will be the presenting sponsor of Funk Out Cancer, a concert and silent auction that raises money for the UW Carbone Cancer Center. An annual event held in memory of Kate Gates Falaschi, Funk Out Cancer will take place on October 19, 2013, at Madison's Barrymore Theatre

Achieving Personal Harmony and Balance During Cancer
(Family Features) What if after surviving your first cancer diagnosis at the age of 51, you were re-diagnosed just 18 months later? Metastatic colorectal cancer patient Dave Johnson experienced that first-hand, and was initially reluctant and scared to tell his family, friends and co-workers.

Gabriel Lee, M.D., Joins Houston-Bay Area Gastroenterology
Bay Area Gastroenterology welcomes Board Certified Gastroenterologist Dr. Gabriel Lee to the group -- expanding the scope of services they are able to offer in general and interventional gastroenterology.

Pure-Ecommerce.com Announces Its Third Annual Breast Cancer Awareness Month Business Giveaway
In honor of Breast Cancer Awareness Month and survivors, Pure-Ecommerce.com is excited to announce its Third Annual Breast Cancer Awareness Month Business Giveaway for breast cancer survivors in Canada and the US. The winner will receive a complete ready-to-go ecommerce business along with 40 hours of award-winning one-on-one training and consultation

Plandai Primed to Fight Colon Cancer
Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, notes that due to the high absorption rates in its flagship offerings, Plandai Biotechnology Inc. (OTCQB: PLPL) may soon enter the colon cancer fighting arena.

Bavarian Nordic's CV-301 Cancer Immunotherapy Candidate Shows Promise in Colorectal Cancer
KVISTGAARD, Denmark, May 29, 2013 - Bavarian Nordic A/S (OMX: BAVA) announced today that promising data from a Phase 2 trial of its CV-301 cancer immunotherapy candidate in patients with resected metastatic colorectal cancer were recently published in the Annals of Surgery

UPDATE: First US Patent for Vaccine Treatment of Obesity Is Awarded to Braasch Biotech LLC
Braasch Biotech LLC, a biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced the company was assigned US Patent 8,425,914 for vaccination methods in the treatment of obesity.

Overall U.S. Costs of Cancer to Spike to $158 Billion by 2020
TriMark Publications (http://www.trimarkpublications.com), a global leader in biotechnology, healthcare and life sciences publishing, announces the release of its Cancer Diagnostic Testing report. Cancer diagnostic testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment

First US Patent for Vaccine Treatment of Obesity Is Awarded to Braasch Biotech LLC
Braasch Biotech LLC, a biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced the company was assigned US Patent 8,425,914 for vaccination methods in the treatment of obesity.

Colorectal Surgeon in Houston Highlights Importance of Colon Cancer Screenings and Treatment Options
In light of Colon Cancer Awareness Month, Houston colorectal surgeon Dr. Eric Haas and his fellow medical professionals at Colorectal Surgical Associates strive to enlighten the public about the importance of colon cancer screenings. According to Dr

Soricimed's Peptides Used to Detect Ovarian and Prostate Cancer
Soricimed Biopharma Inc., a private clinical stage company developing novel cancer therapeutics and diagnostics, reported results from molecular imaging investigation that provided a proof-of-concept for the use of SOR peptides to detect and potentially treat ovarian, breast, thyroid, prostate and colon cancer

Houston's Bay Area Gastroenterology Specialists Launch Colorectal Cancer Awareness Month
The Bay Area Gastroenterology consultants remain committed to reducing the number of deaths from colorectal cancer -- speaking during March on the benefits of prevention and early screening in recognition of Colorectal Cancer Awareness month.

Manhattan Endoscopy Center Expands Free Colonoscopy Program for Uninsured New Yorkers in Partnership With Settlement Health and The Bowery Mission During Colorectal Cancer Awareness Month
In an effort to improve patient care for uninsured New Yorkers, Manhattan Endoscopy Center LLC (MEC), Manhattan's most advanced and largest endoscopy center, has announced their commitment to advocating for timely colon cancer screening through their partnership with Settlement Health and The Bowery Mission

GE Healthcare Research Determines Bad Habits Add $33.9 Billion to Annual Global Cost of Cancer
GE Healthcare today released secondary research findings indicating that bad habits and lifestyle choices are contributing approximately $33.9 billion annually to the costs related to cancer. Furthermore, the same research revealed that by reducing bad habits, global healthcare systems could potentially save $25 billion each year.

GE Healthcare Survey Shows People Don’t Associate Bad Habits with Breast Cancer
New research commissioned by GE Healthcare, undertaken by TNS in eight countries1 last month, has revealed that adults are unaware of the link between bad habits such as smoking, excessive alcohol consumption or physical inactivity and breast cancer.

Equity Brief: Ratings Changes for December 20th: SASR, SD, SGY, SLGN, SNSS, ST, STN, TAP
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network (http://bit.ly/equitybriefdaily) and Equity Brief:

Given Imaging Reports New Studies on PillCam(R) COLON 2 Presented at UEG Week
Given Imaging Ltd

Given Imaging Submits PillCam(R) COLON 2 Application to FDA for U.S. Regulatory Clearance
Given Imaging Ltd (NASDAQ: GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced that it has filed a U.S. Food and Drug Administration (FDA) application seeking regulatory clearance to market its PillCam® COLON 2 for visualization of the lower gastrointestinal tract.

Florida LASIK Surgeon on Latest Findings in Eye Care
Dr. Marc Bosem, a Ft. Lauderdale Ophthalmologist, is keeping up on the latest trends in the field as more and more eye care specialists are utilizing the standard eye exam for much more than eye health. New practices and technology in routine eye exams can provide a more comprehensive way of detecting and diagnosing problems not only in the eye, but in other parts of the body as well

Winthrop-University Hospital Physician Uses Miniature Microscope to Examine Live Tissue at the Cellular Level During Endoscopy
Stavros Stavropoulos, MD, Director of Gastrointestinal Endoscopy and the Advanced Endoscopy Program at Winthrop-University Hospital, is using the world's smallest microscope to view internal tissues at the cellular level in real time during endoscopies

Neighborhood Healthfest Offers Activities, Screenings, Family Fun
Free back-to-school physicals. Raffle prizes. Free health screenings for adults. Refreshments and kids' games. Saint Joseph Hospital is celebrating good health and inviting the community to its Neighborhood Healthfest from noon to 3 p.m. on August 5 in a tent at the Stone parking lot, 2837 N. Sheridan Road, Chicago.

Barbecue-With-the-Docs Program Targets Men's Health Issues
Men can enjoy a tasty barbecue dinner while learning how to live healthier and happier lives at a program, "Grills, Guys and Good Health" from 6 to 8 p.m. on July 24 at The Standard Bar, 1332 N. Milwaukee Ave., Chicago. Sponsored by Saints Mary and Elizabeth Medical Center (SMEMC), the program will feature six doctors from a wide range of specialties.

New Journal Article Highlights Value of Third Eye(R) Retroscope(R) Device for Patients Undergoing Surveillance or Diagnostic Colonoscopies
Avantis Medical Systems today announced publication of an article in the World Journal of Gastroenterology showing that Third Eye® colonoscopy significantly improves adenoma detection rates in patients undergoing surveillance or diagnostic colonoscopies.(1)

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in AEterna Zentaris, Inc. of Class Action Lawsuit and the Deadline of August 14, 2012 to Seek a Lead Plaintiff Position
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased AEterna Zentaris, Inc. ("AEterna" or the "Company") (NASDAQ: AEZS) securities between February 3, 2010 and April 1, 2012 (the "Class Period").

Sourcefire Chief Executive Officer Takes Medical Leave of Absence
Sourcefire, Inc. (NASDAQ: FIRE), a leader in intelligent cybersecurity solutions, today announced that the Company's Chief Executive Officer, John Burris, has taken a medical leave of absence to undergo a series of treatments for colon cancer. The Board of Directors has named Martin F

GlobeImmune's GI-4000 in Combination With Gemcitabine Following Surgery Shows Evidence of an Improvement in Survival in a Phase 2b Clinical Trial With Ras Mutation Positive Pancreas Cancer
GlobeImmune, Inc., today announced that GI-4000 in combination with gemcitabine showed evidence of an improvement in overall survival for subjects with Ras mutation positive pancreas cancer with microscopic residual disease after surgery (R1 subjects). The initial Phase 2b data were presented by Donald A. Richards, M.D., Ph.D

Houston Colon Surgeon Lectured at Annual ASCRS Meeting
At the annual scientific meeting for the American Society of Colon and Rectal Surgeons (ASCRS), Dr. Eric Haas, a colon and rectal surgeon in Houston, delivered several presentations focused on a range of laparoscopic surgical and colon cancer topics. Held on June 2-6, 2012 at the Henry B

Houston's Bay Area Gastroenterology Works to Reduce Deaths From Colon Cancer, Encourages Early Colon Screening With Advanced, Less Invasive Virtual Colonoscopy
The Bay Area Gastroenterology consultants work to reduce the number of colon cancer deaths by offering patients a less invasive colon cancer screening option, Virtual Colonoscopy.

Taiho Pharmaceutical Unveils Data on Eight Novel Anticancer Compounds in Bid to Become a New Global Leader in Oncology
Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President: Masayuki Kobayashi), the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies

Dietary fiber nurtures health-promoting gut bacteria
Dietary fiber promotes a shift in the gut toward different types of beneficial bacteria, according to a University of Illinois study.

How infections in liver and stomach can lead to cancer
Chronic inflammation of liver, colon or stomach, often caused by viral or bacterial infections, is one of the biggest risk factors for cancer in these organs.

Healthy habits can help keep diseases at bay
Five new studies have provided evidence to support a range of healthy behaviours that people can follow to prevent illness and improve their overall health.

Spinach can offset harmful effects of carcinogens on cancer stem cells
Scientists including one of Indian origin have for the first time traced the actions of a known carcinogen in cooked meat to its complex biological effects on microRNA and cancer stem cells.

Mum of Robin Gibb's love child skips singer's funeral
The mother of Robin Gibb's love child, Claire Yang did not attend the singer's funeral, as Gibb's wife Dwina was adamant that she did not.

Maurice Gibb's ashes to be taken to brother Robin's funeral
The ashes of Robin Gibb's twin brother Maurice will be taken to the singer's funeral on Friday - in the form of precious stones.

INNO-GENE, A WARSAW STOCK EXCHANGE LISTED COMPANY IS THE FIRST IN THE WORLD TO DEVELOP ACCURATE DNA TESTING FOR CANCER AND PLANS TO ENTER THE US MARKET.
PRESS RELEASE

Given Imaging Initiates Pivotal Trial for PillCam(R) COLON 2 in Japan
Given Imaging (NASDAQ: GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced the initiation of a pivotal PillCam® COLON 2 study in Japan intended to support the Company's planned regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA).

Aspirin significantly cuts cancer risk
A daily dose of aspirin can sharply reduce the risk of death from a wide range of cancers, a new study has suggested.

Hot chemo baths may help fight stomach and colon cancer
A handful of doctors are trying to prove that a hot chemo bath offers a fresh look at ways of fighting against even aggressive forms of stomach and colon cancer.

25 pc of Canadians exceed safe limit of calories
Poor eating habits of most Canadians are making them more susceptible to obesity, a new study has revealed.

Additives in hot dogs may not cut incidences of colon cancer
It was mandated that that amount of nitrite in hot dogs should be reduced, as it was believed that the compound could cause colon cancer.

Stalin's only daughter Svetlana Peters who opposed communism dies of colon cancer
Former Russian dictator Joseph Stalin's only daughter, Svetlana Peters, passed away after battling colon cancer in Wisconsin, United States

Saudi Arabia's Crown Prince passes away
Saudi Arabia's Crown Prince Sultan Bin Abdul Aziz has died abroad after a prolonged illness, the country's Royal Court has said in a statement.

Southampton Varsity's research proves aspirin reduces cancer rates in people with hereditary risk
Research has finally provided proof that taking a regular dose of aspirin reduces the long-term risk of cancer in people with a family history of the disease by around 60 per cent.

Bacterium may play role in colorectal cancers
A new study has found strikingly high levels of a bacterium in colorectal cancers, suggesting that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it.

Comment on this story

Share